deltatrials
Completed PHASE2 INTERVENTIONAL NCT00006256

Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer

Concurrent Taxol (Paclitaxel) and Definitive Breast Radiation Therapy in Early Stage Breast Cancer Following Four Cycles of Adriamycin/Cytoxan Chemotherapy

Sponsor: Case Comprehensive Cancer Center

Conditions Breast Cancer
Interventions adjuvant therapy paclitaxel radiation therapy
Updated 17 times since 2017 Last updated: Nov 29, 2023 Started: Jun 8, 2000 Primary completion: Nov 30, 2005 Completion: Nov 20, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Breast Cancer, this trial is completed. The trial is conducted by Case Comprehensive Cancer Center and has accumulated 17 data snapshots since 2000. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshot~Mar 2019 – ~Mar 2020 · 12 months · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Sep 2021 · 6 months · monthly snapshot~Sep 2021 – ~Jun 2022 · 9 months · monthly snapshot~Jun 2022 – ~Nov 2022 · 5 months · monthly snapshot~Nov 2022 – ~Feb 2023 · 3 months · monthly snapshot~Feb 2023 – ~Aug 2023 · 6 months · monthly snapshot~Aug 2023 – ~Dec 2023 · 4 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Dec 2023 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  5. Aug 2023 — Dec 2023 [monthly]

    Active Not Recruiting PHASE2

▶ Show 12 earlier versions

  1. Feb 2023 — Aug 2023 [monthly]

    Active Not Recruiting PHASE2

  2. Nov 2022 — Feb 2023 [monthly]

    Active Not Recruiting PHASE2

  3. Jun 2022 — Nov 2022 [monthly]

    Active Not Recruiting PHASE2

  4. Sep 2021 — Jun 2022 [monthly]

    Active Not Recruiting PHASE2

  5. Mar 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE2

  6. Jan 2021 — Mar 2021 [monthly]

    Active Not Recruiting PHASE2

  7. Mar 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

  8. Mar 2019 — Mar 2020 [monthly]

    Active Not Recruiting PHASE2

  9. Jun 2018 — Mar 2019 [monthly]

    Active Not Recruiting PHASE2

  10. Feb 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

  11. Feb 2017 — Feb 2018 [monthly]

    Active Not Recruiting PHASE2

  12. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Jun 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Case Comprehensive Cancer Center
Data source: Case Comprehensive Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations